Latest Breaking News On - E shelley hwang - Page 1 : comparemela.com

FDA Committee Gives New Cancer Surgery Tech a Positive Vote

Although most of the FDA's Medical Imaging Drugs Advisory Committee supported LUMISIGHT (pegulicianine), which aims to detect residual cancer during lumpectomy, some cite safety concerns.

United statesDana farber cancer instituteJohns hopkinsBarbara smithHaroldj bursteinKimberlye applegateAndrea richardsonDavidb hackneyE shelley hwangChengjie xiongJorge ferrerFreya schnabelBeth israel deaconess medical centerCommittee expressesWashington university school of medicineLumicell inc

Researchers develop gene classifier to predict DCIS risk of cancer progression

A team of researchers mapping a molecular atlas for ductal carcinoma in situ (DCIS) has made a major advance toward distinguishing whether the early pre-cancers in the breast will develop into invasive cancers or remain stable.

Graham colditzCarlo maleySusang komenE shelley hwangArizona state school of life sciencesNational institutes of healthWashington university at stNational cancer instituteDepartment of defenseDanish cancer societyLundbeck foundationBreast cancer research foundationCaixa foundationStanford university medical centerHuman tumor atlas networkTranslational breast cancer consortium

Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study

Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study
bmj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bmj.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomNoord hollandCity ofYat hee liuBriana menegazJelle wesselingMichael schaapveldYi renTerry hyslopThomas lynchDeborah collyarElinor sawyerSamantha thomasChiara crestaDanalyn byng

Gene Classifier Predicts Breast Cancer Progression

The predictive model could reduce overtreatment of women with breast pre-cancers called ductal carcinoma in situ.

E shelley hwangDuke cancer instituteHuman tumor atlas networkStanford university medical centerNational cancer instituteMoonshot initiativeCancer cellRob westStanford university medicalNational cancerBreast cancerDuctal carcinoma in situBreast cancer cells

New gene classifier can predict the risk of cancer cells recurring or progressing

A team of researchers mapping a molecular atlas for ductal carcinoma in situ (DCIS) has made a major advance toward distinguishing whether the early pre-cancers in the breast will develop into invasive cancers or remain stable.

Susang komenGraham colditzCarlo maleyE shelley hwangEmily hendersonBreast cancer research foundationDuke cancer instituteHuman tumor atlas networkNational cancer instituteNational institutes of healthLundbeck foundationDepartment of defenseTranslational breast cancer consortiumCaixa foundationArizona state school of life sciencesStanford university medical center